体外膜肺氧合
心源性休克
多巴酚丁胺
医学
微循环
心脏病学
麻醉
血流动力学
耐火材料(行星科学)
休克(循环)
内科学
血流
心肌梗塞
天体生物学
物理
作者
Juliette Chommeloux,Santiago Montero,Guillaume Franchineau,Guillaume Lebreton,Nicolas Bréchot,Pétra Barhoum,Lucie Lefèvre,Marc Pineton de Chambrun,Guillaume Hékimian,Charles Edouard Luyt,Alain Combes,Matthieu Schmidt
标识
DOI:10.1016/j.jcrc.2022.154090
摘要
Venoarterial extracorporeal membrane oxygenation (VA ECMO) effectively supports refractory cardiogenic shock (rCS), and sustains macro- and microcirculations. We investigated the respective impact of increasing VA ECMO flow or dobutamine dose on microcirculation in stabilized VA ECMO–treated patients with rCS. In this prospective interventional study, we included consecutive intubated patients, with ECMO-supported rCS and hemodynamic stability, able to tolerate stepwise incremental dobutamine doses (from 5 to 20 gamma/kg/min) or ECMO flows (progressive increase by 25% above baseline ECMO flow. Baseline was defined as the lowest VA ECMO flow and dobutamine 5 μg/kg/min (DOBU5) to maintain mean arterial pressure (MAP) ≥ 65 mmHg. Macro- and microcirculations were evaluated after 30 min at each level. Fourteen patients were included. Macro- and microcirculations were assessed 2 [2–5] days post-ECMO onset. Dobutamine-dose increments did not modify any microcirculation parameters. Only the De Backer score tended to be reduced (p = 0.08) by ECMO-flow increments whereas other microcirculation parameters were not affected. These findings did not differ between patients successfully weaned-off ECMO (n = 6) or not. When macrocirculation has already been restored in patients with ECMO-supported rCS, increasing dobutamine (above 5 μg/kg/min) or ECMO flow did not further improve microcirculation.
科研通智能强力驱动
Strongly Powered by AbleSci AI